| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5584317 | Endocrinología y Nutrición | 2016 | 9 Pages |
Abstract
Improved blood glucose control associated to integrated pump/CGM results in a decreased incidence of diabetes-related complications and improves life expectancy as compared to MDI. Using recommended thresholds from the World Health Organization and previous coverage decisions about health technologies in Colombia, it is a cost-effective alternative to MDI for the treatment of type 1 diabetes in Colombia.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Ana Maria Gomez, Rafael Alfonso-Cristancho, John Jairo Orozco, Peter Matthew Lynch, Diana Prieto, Rhodri. Saunders, Stephane Roze, Juan Esteban Valencia,